Avid Bioservices, Inc.
Apr 9, 2018

Avid Bioservices to Participate at INTERPHEX 2018

TUSTIN, Calif., April 09, 2018 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated contract development and manufacturing organization (CDMO) working to improve patient lives by providing high quality development and manufacturing services to biotechnology and pharmaceutical companies, today announced that the company will participate in the International Pharmaceutical Expo (INTERPHEX) 2018.  The company's activities will include participation in a conference panel focused on biologics outsourcing, as well as delivering a presentation on single-use manufacturing of biopharmaceuticals.  INTERPHEX 2018 is being held April 17-19, 2018 at the Javits Center in New York, NY.

Details of Avid's activities at INTERPHEX 2018 are as follows:

Sponsored by the Parenteral Drug Association (PDA), INTERPHEX brings over 11,000 global industry professionals and more than 630 industry leading suppliers together to "Learn it, Experience it, Procure it" through a unique combination of no cost technical conference, exhibits, demonstrations, roundtables, partnering opportunities and networking to leverage quality, efficiency and cost effectiveness in today's ever-changing global market.  For additional details on INTERPHEX 2018, please visit: http://www.interphex.com/.

About Avid Bioservices, Inc.
Avid Bioservices is a dedicated contract development and manufacturing organization (CDMO) focused on development and cGMP manufacturing of biopharmaceutical products derived from mammalian cell culture.  The company provides a comprehensive range of process development, high quality cGMP clinical and commercial manufacturing services for the biotechnology and biopharmaceutical industries.  With 25 years of experience producing monoclonal antibodies and recombinant proteins in batch, fed-batch and perfusion modes, Avid's services include cGMP clinical and commercial product manufacturing, purification, bulk packaging, stability testing and regulatory strategy, submission and support.  The company also provides a variety of process development activities, including cell line development and optimization, cell culture and feed optimization, analytical methods development and product characterization.  www.avidbio.com


Kelly Pisarev Lord

Avid Bioservices, Inc.

(800) 987-8256

Stephanie Diaz (Investors)

Vida Strategic Partners



Tim Brons (Media)

Vida Strategic Partners



Primary Logo

Source: Avid Bioservices, Inc

News Provided by Acquire Media